Get started
PHARMASGP HOLDING SEPP

PHARMASGP HOLDING SE

27.2EURD
0.00.00%
At close at May 29, 15:36 GMT
EUR
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

PSG fundamentals

Key facts

Market capitalization‪326.40 M‬EUR
Dividend yield (indicated)1.87%
Price to earnings Ratio (TTM)16.23
Basic EPS (TTM)1.68EUR
Founded2019
Employees (FY)91
CEOPeter Gerckens
Websitepharmasgp.com
About

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. It distributes its products under the Baldriparan, Formigran, Spalt, Kamol, RubaXX, Restaxil, DESEO, and NERADIN brands. The company was founded in 2012 and is headquartered in Graefelfing, Germany.

Ownership
‪‪11.51 M‬‬
Closely held shares
‪‪10.33 M‬‬ (89.76%)
Free Float shares
‪‪1.18 M‬‬ (10.24%)
Closely held shares
‪‪10.33 M‬‬ (89.76%)
Free Float shares
‪‪1.18 M‬‬ (10.24%)
Capital structure
Market cap
‪‪326.40 M‬‬
Debt
‪‪66.32 M‬‬
Cash & equivalents
‪‪29.32 M‬‬
Enterprise value
‪‪363.40 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪326.40 M‬‬
Price to earning ratio (P/E)
16.23x
Price to sales ratio (P/S)
2.56x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
16.23x
Price to sales ratio (P/S)
2.56x
Valuation ratios
‪0.00‬
‪0.70‬
‪1.40‬
‪2.10‬
‪2.80‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪10.0%‬
‪12.1%‬
‪14.2%‬
‪16.3%‬
‪18.4%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪9.00 M‬‬
‪‪18.00 M‬‬
‪‪27.00 M‬‬
‪‪36.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪9.00 M‬‬
‪‪18.00 M‬‬
‪‪27.00 M‬‬
‪‪36.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪9.00 M‬‬
‪‪18.00 M‬‬
‪‪27.00 M‬‬
‪‪36.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Health Brands
Beauty Brands
By country
Period: 2024
Germany
Italy
Austria
Other European Countries

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
‪‪24.00 M‬‬
‪‪32.00 M‬‬
Actual
Estimate
Earnings
Next:Sep 25, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪0.12‬
‪0.24‬
‪0.36‬
‪0.48‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
30.43%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
5.00%
Next payment
0.51
Next ex-date
Jun 26, 2025
Next pay date
Jul 1, 2025
Dividend history
‪0.0%‬
‪1.6%‬
‪3.2%‬
‪4.8%‬
‪6.4%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.35‬
‪0.70‬
‪1.05‬
‪1.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−25.00 M‬‬
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Assets
Liabilities